Background: Microvascular rarefaction is a hallmark of essential hypertension. We measured the skin capillary density in nondiabetic hypertensive subjects with effective antihypertensive treatment and evaluated possible correlations with arterial blood pressure (BP).
I
n essential hypertension (EH), the microcirculation (arteriolar and capillary) plays a role in increasing peripheral resistance by decreasing the number of vessels per unit of tissue volume. 1, 2 This phenomenon is termed microvascular rarefaction. Ruedemann 3 described, in 1933, this phenomenon in the conjunctiva of hypertensive patients. It has since been confirmed by different investigators in humans and in different tissues in the majority of experimental models of hypertension. 4 -6 Prewitt et al 7 were the first to make a distinction between functional rarefaction and structural rarefaction. The former would be due to excessive (but reversible) vasoconstriction causing occlusion of resistance arterioles and nonperfusion of distal capillaries. Structural rarefaction would be due to the anatomic absence of certain arterioles and capillaries.
In this context, skin capillary rarefaction of subjects with EH seemed to be a cause rather than a consequence of elevated blood pressure (BP). 8 Moreover, not only baseline (functional) skin capillary density, 9 but also maximal postocclusive capillary recruitment resulting from reactive hyperemia, 10 have been shown to be inversely correlated with BP levels in hypertensive patients.
Intravital video-microscopy is the only method allowing direct visualization of skin capillaries without the use of intravenous fluorescent dyes. 11 Nevertheless, intravital video-microscopy does not evidence nonperfused capillaries because it relies on the presence of red blood cells. Different procedures, such as venous congestion and postocclusive hyperemia, have been used to achieve exposure of nonperfused skin capillaries. 12 In the present study, maximal skin capillary density (anatomic or structural density) was evaluated using venous congestion, which is known to increase the red blood cell content inside capillaries. 13, 14 However, it is not known whether the reversal of microvascular rarefaction would result in a chronic reduction in arterial pressure in effectively treated patients with EH. It has been suggested that antihypertensive therapy should also be targeted to prevent or revert functional and structural changes of the microcirculation. 15 It is also worth mentioning that the reduction in arterial pressure induced by different classes of antihypertensive agents is not well correlated either with normalization of microvascular function or with the protection from target organ damage in patients with EH. 11, 16, 17 Thus, in the present study we evaluated the skin capillary density in essential hypertensive patients under chronic and effective antihypertensive treatment. To this aim we designed an observational study investigating skin capillary density of nondiabetic hypertensive patients under effective antihypertensive treatment for at least 12 months with different classes of drugs in comparison to capillary density of previously untreated hypertensive patients and normotensive subjects.
Methods

Subjects
We included 76 consecutive outpatients with EH treated with antihypertensive agents from different pharmacologic classes, who had their high BP effectively controlled during at least 12 months (BP Ͻ 140/90 mm Hg), as determined by triplicate office measurements (Dinamap pro 400V2, General Electric, Tampa, FL). Twenty-seven (36%) of the 76 treated patients were taking monotherapy (diuretics 2, ␤-blockers 8, calcium channel blockers 8, angiotensin-converting enzyme (ACE) inhibitor 1, angiotensin receptor blockers 7, centrally acting drug 1) and 49 (64%) received polytherapy. Twenty-four age-and sexmatched patients with recently discovered and nevertreated hypertension were selected in the ambulatory BP monitoring unit. Seventy normotensive (BP Ͻ 140/90 mm Hg) age-and sex-matched healthy control subjects who were members of the hospital staff or subjects examined for clinical evaluation and found healthy were also included in the study. Exclusion criteria were secondary hypertension, types 1 and 2 diabetes mellitus, connective tissue disease, and skin diseases.
The Framingham risk score of the studied subjects was constructed from age, sex, systolic and diastolic BP, total and HDL-cholesterol, and smoking, according to standardized procedures in nondiabetic subjects. 18 All patients gave their informed oral consent to the study, which conformed to the principles outlined in the declaration of Helsinki and was approved by the local ethical committee.
Intravital Video Capillaroscopy
Intravital microscopy was carried out using a standardized well-validated technique. 12, 19 Individuals were studied in the morning between 9 and 11 AM after an overnight fast. The capillaroscopy studies were done in a temperature-controlled room (21°to 24°C) after the subjects had had at least 20 min of semisupine rest. Room temperature was monitored and adjusted if necessary. Subjects were seated with the forearm and hand supported at heart level. Movement of the hand and the forearm was restricted by resting them on a splint surrounded by a vacuum pillow (a specially constructed pillow filled with polyurethane foam that can be molded to any desired shape by creating a vacuum). We used video-microscopy with an epi-illuminated fiberoptic microscope containing a 100-W mercury vapor lamp light source and a M200 objective (Moritex micro-Scopeman MS-500C, Tokyo, Japan), final magnification ϫ200. Microscopic images were transferred for storage and further analysis to a PC with a video image converter (Microvision, Evry, France). The skin of the dorsum of the middle phalanx of the nondominant hand was examined. We defined an approximately 3-by 3-mm skin area on the middle third of the phalanx. Four microscopic fields (1.15 mm 2 each) were randomly chosen in this area for recording and measurements. In previous careful experiments in control and hypertensive subjects (unpublished data), we have shown that there was no difference between results obtained from 4 or more (until 10) fields from this selected skin area. Each field was analyzed offline to count the total number of visible (ie, perfused capillaries). Thus, for each studied subject, four images were analyzed at baseline and four during venous congestion. Capillary density was determined twice by two investigators in a blinded fashion. The clinical characteristics and the family history of the study subjects were not available to either investigator during capillary counting. Reproducibility was first assessed by examining an identical area of skin; intraobserver repeatability of data analysis was assessed by reading the same images in a blinded manner on two separate occasions (n ϭ 20; coefficient of variability 4.3%). To assess interobserver repeatability, a second observer independently assessed capillary density in the same images (n ϭ 20; coefficient of variability 5.9%). Capillaroscopy is only possible in the lighter pigmented subjects 20 ; therefore, only whites were included in the present study. Skin temperature was monitored throughout the study with a temperature probe on the dorsum of the left index finger (Perimed, Stockholm, Sweden).
Maximization of Visualized Skin Capillaries
It has been shown that venous congestion maximizes the number of visible capillaries much more than reactive hyperemia. 12 A BP cuff was applied to the wrist and the cuff was then inflated and maintained at 60 mm Hg for 2 min; additional images were then recorded during venous congestion.
Hemodynamic Measurements
Brachial BP and heart rate were measured with a semiautomatic oscillometric device (Dinamap PRO 400V2, General Electric) with appropriate cuff size in the sitting position and the mean of three measurements obtained at 1-to 2-min intervals was calculated. Aortic pulse wave velocity (PWV) was determined using an automatic device (SphygmoCor system, PWV Medical, Sydney, Australia), which allows the online pulse wave recording and calculation of PWV with two transducers, positioned over the common carotid artery and the femoral artery. 21 Aortic systolic BP and augmentation index (AI) were calculated as previously described and validated. 22 
Statistical Analysis
The results were expressed as mean Ϯ SEM. Comparisons between the different groups were made with one-way ANOVA or Pearson 2 analyses when indicated. When an overall difference was detected by ANOVA, the post hoc Bonferroni-Dunn multiple comparisons test was used to localize the statistically significant differences. Mean capillary density before and during venous occlusion was compared using the Student paired t test and the relationship between variables was evaluated by multiple linear regressions. Differences with P values of less than .05 were considered significant. All calculations were made by computer-assisted analyses using a commercially available statistical package (Statview 5.0, SAS Institute, Cary, NC). Table 1 shows the characteristics and biochemical data of the study subjects. Table 2 and Fig. 1 show capillaroscopy data obtained at baseline and after 2 min of venous occlusion at 60 mm Hg in treated (n ϭ 76) and untreated (n ϭ 24) hypertensive patients, in comparison to normotensive subjects (n ϭ 70). Mean capillary density at baseline was significantly lower in untreated than in treated hypertensive patients (P Ͻ .001) or in normotensive controls (P Ͻ .001). During venous occlusion, capillary density increased significantly in all groups of subjects. Maximal capillary density (during venous occlusion) was significantly higher in hypertensive treated than in untreated (P Ͻ .001) patients or in normotensives controls (P Ͻ .001). The increase in capillary density during venous occlusion (capillary recruitment) was significantly higher in treated than in untreated hypertensive patients (P Ͻ .01; Table 2 ). Skin temperature was not different between the three groups of subjects (32.3 Ϯ 0.1, 32.7 Ϯ 0.5, and 32.2 Ϯ 0.1 for normotensives, hypertensives treated, and hypertensives untreated, respectively; P Ͻ .05).
Results
Using univariate correlations, the aortic and brachial systolic BPs were inversely correlated with basal capillary density (r ϭ Ϫ0.35, P Ͻ .05 and r ϭ Ϫ0.27, P Ͻ .05, respectively) and with capillary density during venous occlusion (r ϭ Ϫ0.28, P Ͻ .05 and r ϭ Ϫ0.36, P Ͻ .01) in the group of normotensive subjects. We also observed a trend toward a negative correlation between aortic diastolic BP and basal (r ϭ Ϫ0.25, P ϭ .07) as well as postocclusive (r ϭ Ϫ0.24, P ϭ .09) capillary density in the group of normotensive subjects. A negative correlation was also verified between 5-year (r ϭ Ϫ0.33, P Ͻ .01) and 10-year (r ϭ Ϫ0.31, P Ͻ .05) Framingham risk score and structural capillary density in the group of hypertensive treated patients (Fig. 2) . There was also a trend toward a negative correlation between 5-year (r ϭ Ϫ0.24, P ϭ .052) and 10-year (r ϭ Ϫ0.21, P ϭ .08) Framingham risk score and basal capillary density in the group of hypertensive treated patients. There were no other statistically significant differences between hemodynamic and capillaroscopy data in the three groups of subjects (data not shown).
From multiple regressions analysis (Table 3) , it appeared that: 1) whatever the statistic evaluation, aortic systolic BP was constantly superior to brachial systolic BP or aortic or brachial diastolic BP to characterize the BP level, 2) aortic systolic BP was influenced, in normotensive subjects, only by body mass index (BMI), and in hypertensive subjects (whether treated or not) by sex, BMI, and the presence of antihypertensive therapy. Systolic BP level did not influence significantly the PWV or AI.
In normotensive subjects, capillary density measured either before or during venous occlusion was negatively correlated with aortic (and not brachial) systolic BP (Fig. 3) , even after adjustment to age and smoking.
In hypertensive subjects, capillary density measured either before or during venous occlusion, did not correlate significantly with BP, the major factors influenc- 
FIG. 1. Skin capillary density (number of capillaries/mm
2 ) before (baseline) and during venous occlusion (VO) in normotensive controls (छ, n ϭ 70) and hypertensive treated ( ', n ϭ 76) and untreated (, n ϭ 24) patients. Values are expressed as mean Ϯ SEM. ***P Ͻ 0.001 (ANOVA followed by Bonferroni-Dunn multiple comparisons test). ing capillary density were sex, BMI, smoking, and mostly the presence of antihypertensive drug therapy. During venous occlusion the r 2 value was 0.419 (ie, highly significant).
Plasma cholesterol, PWV, or AI never influenced the studied parameters. The presence of diuretics among the antihypertensive agents did not modify the results.
Discussion
The present study suggests that functional as well as structural skin capillary rarefaction of never-treated EH patients could be reverted in effectively treated patients. Baseline (functional) and maximal (structural) skin capillary densities in hypertensive treated patients were significantly higher when compared to never-treated hypertensive patients or even to normotensive subjects. The increase in the functional number of capillaries could be explained by vasodilation resulting from treatment or by lowering of BP. However, structural (during venous congestion) capillary density was not only normalized in treated hypertensive patients but could exceed levels in normotensive controls. Even if the present observational study did not investigate the direct microvascular actions of antihypertensive treatment on previously untreated patients in relation to their BP-lowering effect, it is reasonable to speculate that effective chronic antihypertensive treatment could reverse structural rarefaction of skin capillaries improving altered angiogenesis of primary hypertension.
This study confirms previous findings [12] [13] [14] 19 showing that skin capillary rarefaction in patients with untreated EH is due both to a reduction of the number of spontaneously perfused capillaries (functional rarefaction) and to a decreased total number of capillaries in the tissue (structural rarefaction). On the other hand, our values of functional and structural skin capillary density are lower than those reported in the mentioned studies. This discrepancy can be accounted for by the use of distinct experimental approaches in the procedures of intravital microscopy. Although earlier studies evaluated capillary density using videotape images, [12] [13] [14] 19 where the number of capillaries was counted during 15-sec to 5-min time periods, thus including continuously as well as intermittently perfused capillaries, in our study skin capillary density was evaluated using the mean values of the number of capillary loops visualized in a series of digital photos, probably Abbreviations in Tables 1 and 2 .
FIG. 3.
Correlations between skin capillary density before (, baseline) (linear --, r ϭ Ϫ0.35, P Ͻ 0.05) and during venous occlusion (छ, VO) (linear ---, r ϭ Ϫ0.28, P Ͻ 0.05) with Aortic systolic blood pressures in normotensive subjects.
reflecting exclusively the number of continuously perfused capillaries. Moreover, the percentage increase in capillary density during venous occlusion, representing capillary recruitment, obtained in the different groups of subjects in the present study (ϳ5% to 8%), were unexpectedly lower than those reported by other investigators, except for the study by Irving et al 23 performed in healthy individuals, which showed an increase in capillary density during venous occlusion of 7.7%. Although these results cannot be readily explained, capillary recruitment in the present work was statistically significant in all groups of individuals.
It is well established that chronic antihypertensive treatment, especially with angiotensin-converting enzyme (ACE) inhibitors, calcium channel blockers, and angiotensin II (AT 1 ) receptor antagonists, reverse structural alterations of small arteries in different vascular beds in hypertensive animals and humans, which can be considered as the first manifestation of target organ damage in hypertensive patients. 24 In this context, there is substantial experimental evidence indicating that the most frequently used classes of antihypertensive agents induce distinct effects on microvascular rarefaction as well as in the increased wall-to-lumen ratio in experimental models of arterial hypertension. 15 On the other hand, a small number of clinical studies investigated the microvascular effects of antihypertensive treatment. Two independent studies compared the effects of treatments with ACE inhibitors with those of ␤-blockers, on the structure of small subcutaneous arteries (100 to 300 m) of patients with EH. 25, 26 Both studies showed that ACE inhibitors, but not ␤-blockers, induce normalization of vascular structure after a 12-month treatment. 26 Moreover, it has been suggested that the ability of antihypertensive agents to normalize microvascular structure is restricted to drugs that present vasodilator activity, such as ACE inhibitors, excluding drugs that lower BP through a reduction in cardiac output (␤-blockers). 16 Our study included treated hypertensive patients irrespective of the pharmacologic class or number of antihypertensive agents used to normalize arterial BP. Considering that the patients were enrolled in the setting of a tertiary university hospital, the majority of them (64%) was using two or three antihypertensive drugs to have their arterial pressure controlled. Thus, it was not possible to compare skin capillary density between patients treated with distinct drugs in monotherapy, as the groups were too small. Notwithstanding, the present study is the first to demonstrate that chronically treated hypertensive patients do not present skin capillary rarefaction. However, Antonios and co-workers 27 reported, in relatively small groups of patients, that capillary density was lower in treated hypertensive patients with typical anginal chest pain than in age-matched normotensive controls. This discrepancy deserves further investigation in larger populations. Mean skin capillary density was 25% to 30% higher in treated compared with untreated hypertensive patients. Even if the mean values of systolic and diastolic arterial pressures of hypertensive treated patients were significantly higher than that of normotensive subjects, they comprised in a reasonable therapeutic range for severely hypertensive patients (ϳ135/80 mm Hg).
Capillary rarefaction has been suggested to contribute to increased systemic vascular resistance observed in EH. 6, 14, 19 Although it is uncertain whether the skin microcirculation is involved in the regulation of systemic vascular resistance and BP, it is widely believed that capillary rarefaction in EH is present not only in the skin but also in different vascular beds such as skeletal muscle. 20, 28 Moreover, skin capillary density, both at baseline and during venous occlusion, appears to be inversely correlated with brachial BP levels in both normotensive 24 and hypertensive subjects. 19 Finally, the presence of skin capillary rarefaction in normotensive offspring of individuals with EH led independent research teams to put forward the hypothesis according to which defective angiogenesis might be involved in the pathophysiology of EH. 8, 29 The present study showed that impaired capillary recruitment in hypertensive patients is enhanced in suitably treated patients. Our results also show that there is a significant negative correlation between skin capillary density and systolic BP in normotensive subjects. However, aortic, but not brachial, BP was involved. Moreover, aortic systolic BP was positively correlated to smoking habits. On the other hand, capillary density was not associated with BP levels in either treated or untreated hypertensive patients. This could be explained by the confounding influence of the distinct vasodilating and proangiogenic effect of the antihypertensive treatment with drugs from dissimilar pharmacologic classes. On the other hand, the lack of correlation in the group of untreated hypertensive patients deserves further investigation, but could eventually be due to the reduced number of patients included in this group or result from a narrower range of BPs compared to the normotensive subjects. Nevertheless, it is worth to note that the lack of correlation between systolic BP and capillary density in hypertensive subjects, either treated or untreated, is associated with significant correlations with other cardiovascular risk factors, such as smoking and being overweight. These findings, as well as the negative relationship between systlic BP and Framingham score, support the possibility that, not only BP, but also other possible risk factors, play a role in the mechanisms of capillary density in hypertensive subjects.
In conclusion, the present study confirms the occurrence of skin capillary rarefaction in EH patients and demonstrates a reversion of both functional and structural capillary rarefaction in patients under effective antihypertensive treatment. Moreover, we evidenced a negative relationship between mean skin capillary density and arterial pressure in normotensive subjects. This relationship should be investigated in hypertensive subjects in conjunction with the other cardiovascular risk factors susceptible to alter skin capillary density. Our results may suggest that skin capillary rarefaction could be an additional independent cardiovascular risk factor in hypertension. The possible pharmacologic correction of capillary rarefaction raises the interesting question of whether the induction of microvascular growth represents a future therapeutic option in the treatment of hypertension.
